| Product Code: ETC9977302 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Stroke Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Stroke Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Stroke Market - Industry Life Cycle |
3.4 United States (US) Stroke Market - Porter's Five Forces |
3.5 United States (US) Stroke Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Stroke Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Stroke Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 United States (US) Stroke Market Revenues & Volume Share, By Gender, 2021 & 2031F |
3.9 United States (US) Stroke Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 United States (US) Stroke Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Stroke Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of risk factors such as hypertension, diabetes, and obesity leading to a higher incidence of strokes. |
4.2.2 Technological advancements in stroke treatment and management, improving patient outcomes and increasing survival rates. |
4.2.3 Growing awareness and education campaigns about the symptoms and importance of early intervention for strokes. |
4.3 Market Restraints |
4.3.1 High cost of stroke treatments and rehabilitation, limiting access for some patient populations. |
4.3.2 Shortage of skilled healthcare professionals specializing in stroke care, impacting the quality and timeliness of treatment. |
4.3.3 Regulatory challenges and reimbursement issues affecting the adoption of new stroke therapies and technologies. |
5 United States (US) Stroke Market Trends |
6 United States (US) Stroke Market, By Types |
6.1 United States (US) Stroke Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Stroke Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Stroke Market Revenues & Volume, By Ischemic Stroke, 2021- 2031F |
6.1.4 United States (US) Stroke Market Revenues & Volume, By Hemorrhagic Stroke, 2021- 2031F |
6.1.5 United States (US) Stroke Market Revenues & Volume, By Transient Ischemic Attack (TIA), 2021- 2031F |
6.2 United States (US) Stroke Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Stroke Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 United States (US) Stroke Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.4 United States (US) Stroke Market Revenues & Volume, By Others Therapy, 2021- 2031F |
6.3 United States (US) Stroke Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Stroke Market Revenues & Volume, By Imaging Test, 2021- 2031F |
6.3.3 United States (US) Stroke Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.3.4 United States (US) Stroke Market Revenues & Volume, By Echocardiogram, 2021- 2031F |
6.3.5 United States (US) Stroke Market Revenues & Volume, By Lumbar Puncture, 2021- 2031F |
6.3.6 United States (US) Stroke Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Stroke Market, By Gender |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Stroke Market Revenues & Volume, By Female, 2021- 2031F |
6.4.3 United States (US) Stroke Market Revenues & Volume, By Male, 2021- 2031F |
6.5 United States (US) Stroke Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Stroke Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.3 United States (US) Stroke Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 United States (US) Stroke Market Revenues & Volume, By Ambulatory Surgical Center, 2021- 2031F |
6.5.5 United States (US) Stroke Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.6 United States (US) Stroke Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.5.7 United States (US) Stroke Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Stroke Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Stroke Market Revenues & Volume, By Direct, 2021- 2031F |
6.6.3 United States (US) Stroke Market Revenues & Volume, By Retail, 2021- 2031F |
6.6.4 United States (US) Stroke Market Revenues & Volume, By Online, 2021- 2031F |
7 United States (US) Stroke Market Import-Export Trade Statistics |
7.1 United States (US) Stroke Market Export to Major Countries |
7.2 United States (US) Stroke Market Imports from Major Countries |
8 United States (US) Stroke Market Key Performance Indicators |
8.1 Average time from symptom onset to treatment initiation, indicating the efficiency of stroke care delivery. |
8.2 Percentage of stroke patients receiving thrombolytic therapy within the recommended time window, reflecting adherence to treatment guidelines. |
8.3 Adoption rate of telemedicine and remote monitoring solutions in stroke care, demonstrating innovation and access to care improvements. |
9 United States (US) Stroke Market - Opportunity Assessment |
9.1 United States (US) Stroke Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Stroke Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Stroke Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 United States (US) Stroke Market Opportunity Assessment, By Gender, 2021 & 2031F |
9.5 United States (US) Stroke Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 United States (US) Stroke Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Stroke Market - Competitive Landscape |
10.1 United States (US) Stroke Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Stroke Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here